美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Innovate Biopharmaceuticals, Inc.

0.5600

0.0000

成交量：- -

成交额：- -

市值：2,314.20万

市盈率：-0.69

高：0.5600

开：0.5600

低：0.5600

收：0.5600

52周最高：1.67

52周最低：0.3701

股本：4,132.50万

流通股本：3,140.15万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.8116

每股收益(LYR):-0.8116

净资产收益率：407.57%

总资产收益率：-258.31%

市净率：4.62

市盈率(LYR):-0.69

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Innovate Biopharmaceuticals, Inc.

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.innovatebiopharma.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Innovate Biopharmaceuticals, Inc.是一家临床阶段的生物技术公司，专注于开发针对自身免疫/炎症疾病的新药。该公司的业务范围包括腹腔疾病，未满足的需求和溃疡性结肠炎的候选药物。由强大的管理团队引领创新，具有药物开发的广泛经验和将新型疗法推向市场的历史。公司在全球拥有超过150项专利的产品。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎国际,美股交易,港股交易,交易美股,股票信息,股价,美股行情,美股打新,港股打新,IPO打新,购买美股,全球投资","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/INNT/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"INNT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INNT\",,,,,undefined,":{"symbol":"INNT","market":"US","secType":"STK","nameCN":"Innovate Biopharmaceuticals, Inc.","latestPrice":0.56,"timestamp":1588363200000,"preClose":0.56,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":31401489,"shares":41324976,"eps":-0.811579,"marketStatus":"休市中","change":0,"latestTime":"05-01 16:00:00 EDT","open":0.56,"high":0.56,"low":0.56,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.811579,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"symbolChange":{"newSymbol":"NMTR","executeDate":"2020-05-04"},"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.56,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INNT\",,,,,undefined,":{"symbol":"INNT","floatShares":31401489,"roa":"-258.31%","roe":"407.57%","lyrEps":-0.811579,"shares":41324976,"dividePrice":0,"high":0.56,"amplitude":0,"preClose":0.56,"low":0.56,"week52Low":0.3701,"pbRate":"4.62","week52High":1.67,"institutionHeld":0,"latestPrice":0.56,"eps":-0.811579,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.811579,"open":0.56},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INNT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-05-08","symbol":"INNT","fiscalQuarterEnding":"2020/03","expectedEps":-0.13,"name":null,"time":"","type":"earning","dateTimestamp":1588910400000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2020-05-04","symbol":"INNT","oldSymbol":"INNT","newSymbol":"NMTR","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1588564800000},{"market":"US","date":"2020-03-20","symbol":"INNT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1584676800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2019-11-07","symbol":"INNT","fiscalQuarterEnding":"2019/09","expectedEps":-0.14,"name":null,"time":"","type":"earning","dateTimestamp":1573102800000,"reportTimeType":"","actualEps":-0.19},{"date":"2019-08-08","symbol":"INNT","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":-0.16,"defaultRemindTime":1565251200000,"name":null,"time":"盘前","dateTimestamp":1565236800000,"actualEps":-0.16}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INNT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INNT\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.innovatebiopharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Innovate Biopharmaceuticals, Inc.是一家临床阶段的生物技术公司，专注于开发针对自身免疫/炎症疾病的新药。该公司的业务范围包括腹腔疾病，未满足的需求和溃疡性结肠炎的候选药物。由强大的管理团队引领创新，具有药物开发的广泛经验和将新型疗法推向市场的历史。公司在全球拥有超过150项专利的产品。","exchange":"NASDAQ","name":"Innovate Biopharmaceuticals, Inc.","nameEN":"Innovate Biopharmaceuticals, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"INNT\",market:\"US\",,,undefined,":null}}